Fisetin and Melanoma: What the Laboratory Research Shows
Fisetin slowed melanoma cells and tumours in mice, alone and alongside sorafenib. It has never been tested in melanoma patients. Here is the evidence.
Fisetin slowed melanoma cells and tumours in mice, alone and alongside sorafenib. It has never been tested in melanoma patients. Here is the evidence.
Fisetin relaxed arteries and lowered blood pressure in hypertensive rats. No human trial has tested it. Here is what the animal studies show.
The first human pharmacokinetic study of fisetin measured what reaches plasma after a 1,000 mg dose. The answer reframes how to read every fisetin label.
A 2026 Mayo Clinic study improved diabetic wound healing with fisetin, and it is the first senolytic shown to work applied after the injury. It was rubbed on the skin, and the senescence readout was messier than the headline suggests.
Fisetin behaves like an antidepressant in mouse despair tests and raises brain serotonin and noradrenaline. Every study is an animal study, and the test used most often is the one with the worst track record of predicting human results.
Fisetin blocks mast cell degranulation in cell and animal models of hives, anaphylaxis, and food allergy, through a receptor most antihistamines don’t touch. What it hasn’t done is get tested in a human with allergies.
Fisetin and rapamycin are two of the most researched compounds in the longevity supplement and off-label pharmaceutical space, and they
There’s no human safety data on fisetin during pregnancy or breastfeeding. Here’s what actually exists (an animal study, not a human one) and why the standard advice is unanimous.
Senescent cells accumulate in aging gut tissue too. Here’s what mouse colitis and Parkinson’s-model research shows about fisetin, the gut lining, and the microbiome.
Fisetin’s reputation rests almost entirely on one mechanism: senolysis, the selective clearance of senescent ‘zombie’ cells. But a separate and
Fisetin selectively clears senescent cells by suppressing the PI3K-Akt-Bcl-2/Bcl-xL survival pathway. Here is what the research actually shows.
Compare fisetin and quercetin as senolytic supplements: mechanisms, preclinical and early human evidence, key differences, and honest evidence limits.